Basic Information
| RNALocate ID: | RLID:01001368 |
| RNA Symbol: | hsa-miR-28-5p |
| Localization: | Cytoplasm |
RNA Information
| RNA Name: | hsa-miR-28 |
| RNA ID: | miRBase:MIMAT0000085 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24918059 |
| Tissue/Cell Line: | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) |
| Method: | Microarray |
| Description: | Data are collected from supplementary Table S2. MiRNA reads in the subcellular fractions. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001367 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01001369 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001370 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11000885 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000886 | Exosome | Brain tissue | 23382797 |
| RLID:11000887 | Exosome | Plasma | 23663360 |
| RLID:11000888 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000021 | Exosome | Seminal fluid | |
| RLID-D:11000284 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-28-5p | Splenic marginal zone lymphoma | MNDR-E-MI-34064 |
| MNDR | hsa-miR-28-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-34065 |
| MNDR | hsa-miR-28-5p | Glomerulosclerosis | MNDR-E-MI-34066 |
| MNDR | hsa-miR-28-5p | Oral squamous cell carcinoma | MNDR-E-MI-34067 |
| MNDR | hsa-miR-28-5p | Medulloblastoma | MNDR-E-MI-34068 |
| MNDR | hsa-miR-28-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-34069 |
| MNDR | hsa-miR-28-5p | Lymphoma | MNDR-E-MI-34070 |
| MNDR | hsa-miR-28-5p | Lymphoma non-hodgkin | MNDR-E-MI-34071 |
| MNDR | hsa-miR-28-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-34072 |
| MNDR | hsa-miR-28-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-34073 |
| MNDR | hsa-miR-28-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-34074 |
| MNDR | hsa-miR-28-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-34075 |
| MNDR | hsa-miR-28-5p | Her2-receptor positive breast cancer | MNDR-E-MI-34076 |
| MNDR | hsa-miR-28-5p | Breast cancer luminal | MNDR-E-MI-34077 |
| MNDR | hsa-miR-28-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-34078 |
| MNDR | hsa-miR-28-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-34079 |
| MNDR | hsa-miR-28-5p | Prostate cancer | MNDR-E-MI-34080 |
| MNDR | hsa-miR-28-5p | Gastric cancer | MNDR-E-MI-34081 |
| MNDR | hsa-mir-28-5p | Gastric cancer | MNDR-E-MI-34082 |
| MNDR | hsa-miR-28-5p | Gastric lymphoma | MNDR-E-MI-34083 |
| MNDR | hsa-miR-28-5p | Alzheimer disease | MNDR-E-MI-34084 |
| MNDR | hsa-miR-28-5p | Intracranial aneurysm | MNDR-E-MI-34085 |
| MNDR | hsa-miR-28-5p | Bladder cancer | MNDR-E-MI-34086 |
| MNDR | hsa-miR-28-5p | Esophageal carcinoma | MNDR-E-MI-34087 |
| MNDR | hsa-miR-28-5p | Dysautonomia familial | MNDR-E-MI-34088 |
| MNDR | hsa-miR-28-5p | Leukemia | MNDR-E-MI-34089 |
| MNDR | hsa-miR-28-5p | Huntington disease | MNDR-E-MI-34090 |
| MNDR | hsa-miR-28-5p | Chorea | MNDR-E-MI-34091 |
| MNDR | hsa-miR-28-5p | Cardiovascular disease | MNDR-E-MI-34092 |
| MNDR | hsa-miR-28-5p | Carotid stenosis | MNDR-E-MI-34093 |
| MNDR | hsa-miR-28-5p | Down syndrome | MNDR-E-MI-34094 |
| MNDR | hsa-miR-28-5p | Parkinson disease | MNDR-E-MI-34095 |
| MNDR | hsa-miR-28-5p | Basal-like breast cancer | MNDR-E-MI-34096 |
| MNDR | hsa-miR-28-5p | Neuroendocrine neoplasia | MNDR-E-MI-34097 |
| MNDR | hsa-miR-28-5p | Pancreatic cancer | MNDR-E-MI-34098 |
| MNDR | hsa-miR-28-5p | Melanoma | MNDR-E-MI-34099 |
| MNDR | hsa-miR-28-5p | Rectum adenocarcinoma | MNDR-E-MI-34100 |
| MNDR | hsa-miR-28-5p | Nephroblastoma | MNDR-E-MI-34101 |
| MNDR | hsa-miR-28-5p | Colon cancer | MNDR-E-MI-34102 |
| MNDR | hsa-miR-28-5p | Myeloproliferative neoplasm | MNDR-E-MI-34103 |
| MNDR | hsa-miR-28-5p | Colon adenocarcinoma | MNDR-E-MI-34104 |
| MNDR | hsa-miR-28-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-34105 |
| MNDR | hsa-mir-28-5p | Ovarian cancer | MNDR-E-MI-34106 |
| MNDR | hsa-miR-28-5p | Prostate adenocarcinoma | MNDR-E-MI-34107 |
| MNDR | hsa-miR-28-5p | Carcinoma ductal breast | MNDR-E-MI-34108 |
| MNDR | hsa-miR-28-5p | Glioblastoma | MNDR-E-MI-34109 |
| MNDR | hsa-miR-28-5p | Glioma | MNDR-E-MI-34110 |
| MNDR | hsa-miR-28-5p | Chordoma | MNDR-E-MI-34111 |
| MNDR | hsa-miR-28-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-34112 |
| MNDR | hsa-miR-28-5p | Osteosarcoma | MNDR-E-MI-34113 |
| MNDR | hsa-miR-28-5p | Inclusion body myositis | MNDR-E-MI-34114 |
| MNDR | hsa-miR-28-5p | Middle cerebral artery infarction | MNDR-E-MI-34115 |
| MNDR | hsa-miR-28-5p | Cervical adenocarcinoma | MNDR-E-MI-34116 |
| MNDR | hsa-miR-28-5p | Gastric adenocarcinoma | MNDR-E-MI-34117 |
| MNDR | hsa-miR-28-5p | Cervical squamous cell carcinoma | MNDR-E-MI-34118 |
| MNDR | hsa-miR-28-5p | Bone-invasive pituitary adenoma | MNDR-E-MI-34119 |
| MNDR | hsa-miR-28-5p | Lung squamous cell carcinoma | MNDR-E-MI-34120 |
| MNDR | hsa-miR-28-5p | Lung adenocarcinoma | MNDR-E-MI-34121 |
| MNDR | hsa-miR-28-5p | Adrenocortical carcinoma | MNDR-E-MI-34122 |
| MNDR | hsa-miR-28-5p | Thyroid carcinoma | MNDR-E-MI-34123 |
| MNDR | hsa-miR-28-5p | Bladder urothelial carcinoma | MNDR-E-MI-34124 |
| MNDR | hsa-miR-28-5p | Pancreatic adenocarcinoma | MNDR-E-MI-34125 |
| MNDR | hsa-miR-28-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-34126 |
| MNDR | hsa-miR-28-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-34127 |
| MNDR | hsa-miR-28-5p | Clear cell renal cell carcinoma | MNDR-E-MI-34128 |
| MNDR | hsa-miR-28-5p | Cholangiocarcinoma | MNDR-E-MI-34129 |
| MNDR | hsa-miR-28-5p | Esophageal cancer | MNDR-E-MI-34130 |
| MNDR | hsa-miR-28-5p | Synovial sarcoma | MNDR-E-MI-34131 |
| MNDR | hsa-miR-28-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-34132 |
| MNDR | hsa-miR-28-5p | T acute lymphoblastic leukemia | MNDR-E-MI-34133 |
| MNDR | hsa-miR-28-5p | Acute t cell leukemia | MNDR-E-MI-34134 |
| MNDR | hsa-miR-28-5p | Adenoma | MNDR-E-MI-34135 |
| MNDR | hsa-miR-28-5p | Breast invasive carcinoma | MNDR-E-MI-34136 |
| MNDR | hsa-miR-28-5p | Hepatocellular carcinoma | MNDR-E-MI-34137 |
| MNDR | hsa-miR-28-5p | B-cell lymphoma | MNDR-E-MI-34138 |
| MNDR | hsa-miR-28-5p | Rheumatoid arthritis | MNDR-E-MI-34139 |
| MNDR | hsa-miR-28-5p | T-cell leukemia | MNDR-E-MI-34140 |
| MNDR | hsa-miR-28-5p | Hodgkin lymphoma | MNDR-E-MI-34141 |
| MNDR | hsa-miR-28-5p | Burkitt lymphoma | MNDR-E-MI-34142 |
| MNDR | hsa-miR-28-5p | Neuromyelitis optica | MNDR-E-MI-34143 |
| MNDR | hsa-miR-28-5p | Skin cutaneous melanoma | MNDR-E-MI-34144 |
| MNDR | hsa-miR-28-5p | Skin melanoma | MNDR-E-MI-34145 |
| MNDR | hsa-miR-28-5p | Colorectal cancer | MNDR-E-MI-34146 |
| MNDR | hsa-miR-28-5p | Nasopharynx carcinoma | MNDR-E-MI-34147 |
| MNDR | hsa-miR-28-5p | Multiple myeloma | MNDR-E-MI-34148 |
| MNDR | hsa-miR-28-5p | Acute lymphocytic leukemia | MNDR-E-MI-34149 |
| MNDR | hsa-miR-28-5p | Uterine cervical neoplasms | MNDR-E-MI-34150 |
| MNDR | hsa-miR-28-5p | Nasopharyngeal cancer | MNDR-E-MI-34151 |
| MNDR | hsa-miR-28-5p | Prostatic neoplasms | MNDR-E-MI-34152 |
| MNDR | hsa-miR-28-5p | Epstein-barr virus infections | MNDR-E-MI-34153 |
| MNDR | hsa-miR-28-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-34154 |
| MNDR | hsa-miR-28-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-34155 |
| MNDR | hsa-miR-28-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-34156 |
| MNDR | hsa-miR-28-5p | Duke C | MNDR-E-MI-34157 |
| MNDR | hsa-miR-28-5p | Tubulovillous adenoma | MNDR-E-MI-34158 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BAG1 | Homo sapiens | RR00209812 |
TOP